Access to MS treatments
We want to see all licenced treatments for MS made available on the NHS, across the UK.
How we decide our policy positions on access to treatment
Our positions are based on multiple sources of evidence, including
- our My MS My Needs survey 2016 which had 11,000 respondents with MS
- policy roundtables with local commissioners, clinicians and healthcare providers, and people living with MS across the UK.